Wei Cao

Title: Wei Cao: Innovator in Arenavirus Research

Introduction

Wei Cao is a prominent inventor based in San Diego, California. He has made significant contributions to the field of virology, particularly in the study of arenaviruses. His innovative work has led to the development of methods aimed at inhibiting the binding of arenaviruses to cellular receptors.

Latest Patents

Wei Cao holds a patent for an "Arenavirus receptor and methods of use." This patent discloses a method for inhibiting the binding of an arenavirus to a cellular receptor. The method involves providing a reagent comprising α-dystroglycan or a portion thereof, which binds to the arenavirus, thereby preventing its attachment to the cellular receptor. The patent also outlines therapeutic compositions for treating and preventing arenavirus infections in at-risk individuals. The methods apply to various arenaviruses, including Lymphocyte Choriomeningitis Virus and Lassa fever virus. Additionally, the patent discusses the use of a dystroglycan null embryonic stem cell line for identifying antiviral compounds that interfere with arenavirus binding.

Career Highlights

Wei Cao is affiliated with the University of Iowa Research Foundation, where he conducts his research. His work has garnered attention for its potential applications in treating viral infections. He has been instrumental in advancing the understanding of arenavirus interactions with cellular receptors.

Collaborations

Wei Cao has collaborated with notable researchers, including Kevin P. Campbell and Michael D. Henry. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field of virology.

Conclusion

Wei Cao's contributions to arenavirus research exemplify the impact of innovative thinking in addressing viral infections. His patent and ongoing research hold promise for future therapeutic advancements.